Analysts expect that Miragen Therapeutics, Inc. (NASDAQ:MGEN) will post $230,000.00 in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Miragen Therapeutics’ earnings. The lowest sales estimate is $50,000.00 and the highest is $400,000.00. Miragen Therapeutics posted sales of $880,000.00 in the same quarter last year, which suggests a negative […]
